242
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Assessment of CYP450 Genetic Variability Effect on Methadone Dose and Tolerance

, , , , , , & show all
Pages 977-986 | Published online: 23 Jun 2014

References

  • Sturgess JE , GeorgeTP , KennedyJL , HeinzA , MullerDJ . Pharmacogenetics of alcohol, nicotine and drug addiction treatments . Addict. Biol.16 ( 3 ), 357 – 376 ( 2011 ).
  • Levy S , VaughanBL , AnguloM , KnightJR . Buprenorphine replacement therapy for adolescents with opioid dependence: early experience from a children’s hospital-based outpatient treatment program . J. Adolesc. Health40 ( 5 ), 477 – 482 ( 2007 ).
  • Nicholls L , BragawL , RuetschC . Opioid dependence treatment and guidelines . J. Manag. Care Pharm.16 ( 1 Suppl. B ), S14 – S21 ( 2010 ).
  • Fucci N , De GiovanniN . Methadone in hair and sweat from patients in long-term maintenance therapy . Ther. Drug Monit.29 ( 4 ), 452 – 454 ( 2007 ).
  • Mattick RP , BreenC , KimberJ , DavoliM . Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence . Cochrane Database Syst. Rev.3 , CD002209 ( 2009 ).
  • Oliver P , KeenJ , RowseG , EwinsE , GriffithsL , MathersN . The effect of time spent in treatment and dropout status on rates of convictions, cautions and imprisonment over 5 years in a primary care-led methadone maintenance service . Addiction105 ( 4 ), 732 – 739 ( 2010 ).
  • Bell J , BurrellT , IndigD , GilmourS . Cycling in and out of treatment; participation in methadone treatment in NSW, 1990–2002 . Drug Alcohol Depend.81 ( 1 ), 55 – 61 ( 2006 ).
  • Elkader AK , BrandsB , DunnE , SelbyP , SprouleBA . Major depressive disorder and patient satisfaction in relation to methadone pharmacokinetics and pharmacodynamics in stabilized methadone maintenance patients . J. Clin. Psychopharmacol.29 ( 1 ), 77 – 81 ( 2009 ).
  • Elkader AK , BrandsB , SelbyP , SprouleBA . Methadone-nicotine interactions in methadone maintenance treatment patients . J. Clin. Psychopharmacol.29 ( 3 ), 231 – 238 ( 2009 ).
  • Crettol S , DeglonJJ , BessonJet al. Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment . Clin. Pharmacol. Ther.78 ( 6 ), 593 – 604 ( 2005 ).
  • Fonseca F , de la TorreR , DiazLet al. Contribution of cytochrome P450 and ABCB1 genetic variability on methadone pharmacokinetics, dose requirements, and response . PLoS ONE6 ( 5 ), e19527 ( 2011 ).
  • Maxwell S , ShindermanM . Optimizing response to methadone maintenance treatment: use of higher-dose methadone . J. Psychoactive Drugs31 ( 2 ), 95 – 102 ( 1999 ).
  • Bao YP , LiuZM , EpsteinDH , DuC , ShiJ , LuL . A meta-analysis of retention in methadone maintenance by dose and dosing strategy . Am. J. Drug Alcohol Abuse35 ( 1 ), 28 – 33 ( 2009 ).
  • Li Y , KantelipJP , Schieveen PGerritsen-van , DavaniS . Interindividual variability of methadone response: impact of genetic polymorphism . Mol. Diagn. Ther.12 ( 2 ), 109 – 124 ( 2008 ).
  • Wang JS , DeVaneCL . Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitro . Drug Metab. Dispos.31 ( 6 ), 742 – 747 ( 2003 ).
  • Wang SC , HoIK , TsouHHet al. CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer . J. Clin. Psychopharmacol.31 ( 4 ), 463 – 469 ( 2011 ). 
  • Chen CH , WangSC , TsouHHet al. Genetic polymorphisms in CYP3A4 are associated with withdrawal symptoms and adverse reactions in methadone maintenance patients . Pharmacogenomics12 ( 10 ), 1397 – 1406 ( 2011 ).
  • Wang SC , HoIK , TsouHHet al. Functional genetic polymorphisms in CYP2C19 gene in relation to cardiac side effects and treatment dose in a methadone maintenance cohort . OMICS17 ( 10 ), 519 – 526 ( 2013 ).
  • Wang SC , HoIK , WuSLet al. Development of a method to measure methadone enantiomers and its metabolites without enantiomer standard compounds for the plasma of methadone maintenance patients . Biomed. Chromatogr.24 ( 7 ), 782 – 788 ( 2010 ).
  • Eap CB , BuclinT , BaumannP . Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence . Clin. Pharmacokinet.41 ( 14 ), 1153 – 1193 ( 2002 ).
  • Trafton JA , MinkelJ , HumphreysK . Determining effective methadone doses for individual opioid-dependent patients . PLoS Med.3 ( 3 ), e80 ( 2006 ).
  • Collett BJ . Opioid tolerance: the clinical perspective . Br. J. Anaesth.81 ( 1 ), 58 – 68 ( 1998 ).
  • Donny EC , BrasserSM , BigelowGE , StitzerML , WalshSL . Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers . Addiction100 ( 10 ), 1496 – 1509 ( 2005 ).
  • Dyer KR , WhiteJM . Patterns of symptom complaints in methadone maintenance patients . Addiction92 ( 11 ), 1445 – 1455 ( 1997 ).
  • Dang VC , ChristieMJ . Mechanisms of rapid opioid receptor desensitization, resensitization and tolerance in brain neurons . Br. J. Pharmacol.165 ( 6 ), 1704 – 1716 ( 2012 ).
  • Tsai HJ , WangSC , TianJNet al. PXR polymorphisms interacted with CYP2B6 polymorphisms on methadone metabolites . J. Clin. Psychopharmacol.33 ( 1 ), 137 – 140 ( 2013 ).
  • NIH Clinical Trial . www.clinicaltrial.gov/ct/show/NCT01059747  
  • Rodi CP , Darnhofer-PatelB , StanssensP , ZabeauM , van den BoomD . A strategy for the rapid discovery of disease markers using the MassARRAY system . BioTechniques Suppl.62–66 , 68 – 69 ( 2002 ).
  • Benjamini Y , Hochberg , Y . Controlling the false discovery rate: a practical and powerful approach to multiple testing . J. Roy. Stat. Soc. Ser. B. (Stat. Method.)57 ( 1 ), 289 – 300 ( 1995 ).
  • Blanken P , HendriksVM , KoeterMW , van ReeJM , van den BrinkW . Craving and illicit heroin use among patients in heroin-assisted treatment . Drug Alcohol Depend.120 ( 1–3 ), 74 – 80 ( 2012 ).
  • Foster DJ , SomogyiAA , DyerKR , WhiteJM , BochnerF . Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patients . Br. J. Clin. Pharmacol.50 ( 5 ), 427 – 440 ( 2000 ).
  • Gerber JG , RhodesRJ , GalJ . Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19 . Chirality16 ( 1 ), 36 – 44 ( 2004 ).
  • Strain EC , BigelowGE , LiebsonIA , StitzerML . Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial . JAMA281 ( 11 ), 1000 – 1005 ( 1999 ).
  • Johnson RE , ChutuapeMA , StrainEC , WalshSL , StitzerML , BigelowGE . A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence . N. Engl. J. Med.343 ( 18 ), 1290 – 1297 ( 2000 ).
  • Masten LW , PetersonGR , BurkhalterA , WayEL . Tolerance to methadone lethality and microsomal enzyme induction in mice tolerant to and dependent on morphine . Drug Alcohol Depend.5 ( 1 ), 27 – 37 ( 1980 ).
  • Volavka J , VerebeyK , ResnickR , MuleS . Methadone dose, plasma level, and cross-tolerance to heroin in man . J. Nerv. Ment. Dis.166 ( 2 ), 104 – 109 ( 1978 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.